Managed care
Vantage Medical Group
Vantage Medical Group was paid $918K by Medicaid between Jan 2018 and Aug 2021, across 523 billing codes. Its largest line is J0135, Injection, adalimumab, 20 mg — 33% of everything it billed.
33Billing provider infoVANTAGE MEDICAL GROUP
CORONA, CA 92881
CORONA, CA 92881
33aNPI1982776050assigned 11/14/2006
33bProvider typeHealth Maintenance Organization
28Total paid$918K
24GClaims550,104
24DCodes billed523
24AFirst – last monthJan 2018 – Aug 2021
Compared with peers
Next to other Health Maintenance Organization providers in California
Rank by total paid#38 of 151
Median peer was paid$59K
This provider vs. median16×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 539,288 | $880K | |
| 2019 | 5,985 | $2K | |
| 2020 | 779 | $15K | |
| 2021 | 4,052 | $21K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0135 | Injection, adalimumab, 20 mg | 33% | 86 | 77 | $300K |
| J3490 | Unclassified drugs | 13% | 2,255 | 1,485 | $117K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.1% | 52,564 | 48,300 | $83K |
| 97010 | 4.7% | 719 | 282 | $43K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 4.4% | 7,790 | 7,631 | $41K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.5% | 22,089 | 20,527 | $32K |
| 97014 | 2.9% | 3,479 | 1,540 | $27K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 2.8% | 242 | 165 | $26K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.3% | 261 | 210 | $21K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.2% | 32,760 | 23,691 | $21K |
| 99222 | Initial hospital care, per day, moderate complexity | 2.1% | 266 | 237 | $20K |
| 95811 | 2.1% | 183 | 119 | $20K |
511 more codes
| 81002 | 1.8% | 6,381 | $17K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.4% | 7,763 | $13K |
| 59425 | 1.4% | 3,747 | $13K | |
| 80053 | Comprehensive metabolic panel | 1.3% | 19,704 | $12K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.2% | 4,688 | $11K |
| 99204 | Doctor's office visit, new patient (more involved) | 1.1% | 808 | $10K |
| 36415 | Collection of venous blood by venipuncture | 1.0% | 6,074 | $9K |
| 81025 | <1% | 5,711 | $8K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 2,142 | $7K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,284 | $7K |
| 3341F | <1% | 49 | $4K | |
| 81001 | <1% | 10,569 | $3K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 438 | $3K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 3,151 | $3K |
| T4527 | Adult sized disposable incontinence product, protective underwear/pull-on, large size, each | <1% | 205 | $3K |
| 81015 | <1% | 362 | $2K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 566 | $2K |
| 92015 | Determination of refractive state | <1% | 106 | $2K |
| T4526 | Adult sized disposable incontinence product, protective underwear/pull-on, medium size, each | <1% | 208 | $2K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 407 | $2K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 53 | $2K |
| 11721 | <1% | 114 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 6,223 | $2K |
| 80061 | Lipid panel | <1% | 13,758 | $2K |
| 96160 | <1% | 737 | $1K | |
| A6402 | Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | <1% | 60 | $1K |
| 85027 | <1% | 3,211 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 11,652 | $1K |
| T4541 | Incontinence product, disposable underpad, large, each | <1% | 963 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 13,151 | $1K |
| T4523 | Adult sized disposable incontinence product, brief/diaper, large, each | <1% | 157 | $893.18 |
| 92250 | <1% | 333 | $801.05 | |
| T4522 | Adult sized disposable incontinence product, brief/diaper, medium, each | <1% | 114 | $800.82 |
| T4535 | Disposable liner/shield/guard/pad/undergarment, for incontinence, each | <1% | 498 | $796.05 |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 214 | $792.00 |
| 99205 | Prolong outpt/office vis | <1% | 257 | $746.20 |
| 99284 | Emergency room visit (serious) | <1% | 6,962 | $735.10 |
| 85610 | <1% | 3,180 | $655.23 | |
| 71045 | Radiologic examination, chest; single view | <1% | 739 | $650.26 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 6,803 | $638.68 |
| 82947 | <1% | 1,420 | $598.47 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 9,896 | $554.92 |
| 84484 | <1% | 3,328 | $532.35 | |
| 82962 | <1% | 2,080 | $512.57 | |
| 80074 | <1% | 1,187 | $504.56 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 167 | $496.60 |
| 99401 | <1% | 749 | $470.95 | |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | <1% | 79 | $470.28 |
| S9083 | Global fee urgent care centers | <1% | 47 | $455.00 |
| 98940 | <1% | 94 | $450.93 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 3,905 | $435.36 |
| 84100 | <1% | 2,801 | $428.79 | |
| 86592 | <1% | 2,222 | $384.90 | |
| 82553 | <1% | 65 | $383.44 | |
| 87070 | <1% | 1,193 | $378.25 | |
| 83690 | <1% | 3,954 | $376.58 | |
| T4528 | Adult sized disposable incontinence product, protective underwear/pull-on, extra large size, each | <1% | 143 | $332.48 |
| G9920 | Screening performed and negative | <1% | 12 | $319.00 |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 85 | $268.92 |
| 99243 | <1% | 26 | $257.12 | |
| 87806 | <1% | 1,117 | $251.65 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 1,628 | $232.10 |
| 83735 | <1% | 4,447 | $230.82 | |
| 3078F | <1% | 1,379 | $200.36 | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 428 | $200.00 |
| 82274 | <1% | 1,060 | $196.59 | |
| 87088 | <1% | 1,138 | $186.11 | |
| 86780 | <1% | 758 | $181.20 | |
| 84703 | <1% | 1,112 | $173.29 | |
| 92235 | <1% | 12 | $159.74 | |
| 99000 | <1% | 2,463 | $159.56 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,189 | $158.73 |
| 81003 | <1% | 1,709 | $155.52 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 2,212 | $148.56 |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 3,613 | $148.46 |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 109 | $135.92 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,379 | $134.06 |
| A4927 | Gloves, non-sterile, per 100 | <1% | 101 | $131.92 |
| A4351 | Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, or silicone elastomer, etc.), each | <1% | 33 | $129.52 |
| 3074F | <1% | 1,752 | $120.96 | |
| A4267 | Contraceptive supply, condom, male, each | <1% | 937 | $114.31 |
| S9088 | Services provided in an urgent care center (list in addition to code for service) | <1% | 15 | $110.00 |
| H1003 | Prenatal care, at-risk enhanced service; education | <1% | 1,955 | $100.92 |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 367 | $98.60 |
| 99283 | Emergency room visit (moderate) | <1% | 7,448 | $88.75 |
| 82550 | <1% | 1,036 | $87.93 | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 3,408 | $79.03 |
| 80076 | <1% | 4,203 | $55.20 | |
| 76536 | <1% | 12 | $54.45 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 7,183 | $53.80 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 74 | $52.10 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 51 | $50.00 |
| 00731 | <1% | 33 | $49.31 | |
| 86704 | <1% | 332 | $40.60 | |
| 86580 | <1% | 3,503 | $39.96 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 90 | $37.69 |
| 86803 | <1% | 1,192 | $37.23 | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 12 | $36.78 |
| 90686 | <1% | 641 | $34.00 | |
| 84439 | <1% | 2,126 | $31.94 | |
| 87641 | <1% | 499 | $29.39 | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 238 | $28.12 |
| 83525 | <1% | 13 | $27.99 | |
| 87077 | <1% | 782 | $24.70 | |
| S9452 | Nutrition classes, non-physician provider, per session | <1% | 781 | $24.00 |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | <1% | 533 | $22.46 |
| 84702 | <1% | 2,097 | $21.93 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,984 | $19.26 |
| 84460 | <1% | 718 | $17.71 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,127 | $17.28 |
| 82728 | <1% | 1,141 | $15.00 | |
| 80320 | <1% | 353 | $14.62 | |
| 82607 | <1% | 2,422 | $13.20 | |
| 82570 | <1% | 2,544 | $9.67 | |
| 83986 | <1% | 296 | $6.84 | |
| 3008F | <1% | 1,783 | $6.65 | |
| 87040 | <1% | 1,012 | $5.78 | |
| 87400 | <1% | 59 | $5.75 | |
| 82043 | <1% | 2,762 | $5.03 | |
| 93000 | <1% | 787 | $3.63 | |
| 85651 | <1% | 444 | $2.13 | |
| 85018 | <1% | 9,014 | $1.89 | |
| 87186 | <1% | 1,580 | $1.49 | |
| S4993 | Contraceptive pills for birth control | <1% | 80 | $0.28 |
| 70450 | Computed tomography, head or brain; without contrast material | 0% | 154 | $0.00 |
| 86765 | 0% | 94 | $0.00 | |
| 97161 | 0% | 336 | $0.00 | |
| 90715 | 0% | 875 | $0.00 | |
| 99072 | 0% | 98 | $0.00 | |
| 90670 | 0% | 2,812 | $0.00 | |
| 86480 | 0% | 977 | $0.00 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 0% | 138 | $0.00 |
| 90648 | 0% | 626 | $0.00 | |
| 82172 | 0% | 151 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 1,264 | $0.00 |
| 85045 | 0% | 347 | $0.00 | |
| 90734 | 0% | 715 | $0.00 | |
| 83970 | 0% | 403 | $0.00 | |
| 1159F | 0% | 1,298 | $0.00 | |
| 99173 | 0% | 6,688 | $0.00 | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 0% | 2,158 | $0.00 |
| 83516 | 0% | 304 | $0.00 | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | 0% | 270 | $0.00 |
| 17110 | 0% | 85 | $0.00 | |
| 82248 | 0% | 549 | $0.00 | |
| 87338 | 0% | 225 | $0.00 | |
| 90658 | 0% | 1,139 | $0.00 | |
| 82652 | 0% | 204 | $0.00 | |
| 99201 | 0% | 281 | $0.00 | |
| 44377 | 0% | 128 | $0.00 | |
| 87660 | 0% | 1,307 | $0.00 | |
| 86900 | 0% | 685 | $0.00 | |
| 83655 | 0% | 1,720 | $0.00 | |
| 80306 | 0% | 400 | $0.00 | |
| 86200 | 0% | 187 | $0.00 | |
| 59025 | Fetal non-stress test | 0% | 643 | $0.00 |
| 90707 | 0% | 994 | $0.00 | |
| 86735 | 0% | 77 | $0.00 | |
| 80354 | 0% | 160 | $0.00 | |
| 82776 | 0% | 187 | $0.00 | |
| 97803 | 0% | 111 | $0.00 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 173 | $0.00 |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 0% | 121 | $0.00 |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 0% | 1,365 | $0.00 |
| 90700 | 0% | 967 | $0.00 | |
| 96152 | 0% | 12 | $0.00 | |
| 80338 | 0% | 43 | $0.00 | |
| 87209 | 0% | 93 | $0.00 | |
| 92552 | 0% | 2,033 | $0.00 | |
| 94664 | 0% | 918 | $0.00 | |
| 87177 | 0% | 93 | $0.00 | |
| 90713 | 0% | 563 | $0.00 | |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 145 | $0.00 |
| 84481 | 0% | 380 | $0.00 | |
| 82565 | 0% | 463 | $0.00 | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 0% | 279 | $0.00 |
| 86696 | 0% | 594 | $0.00 | |
| 90633 | 0% | 1,465 | $0.00 | |
| 83540 | 0% | 1,222 | $0.00 | |
| 99336 | 0% | 14 | $0.00 | |
| 83721 | 0% | 307 | $0.00 | |
| 96103 | 0% | 904 | $0.00 | |
| 94150 | 0% | 162 | $0.00 | |
| 80372 | 0% | 54 | $0.00 | |
| 86003 | 0% | 508 | $0.00 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 0% | 910 | $0.00 |
| 86787 | 0% | 202 | $0.00 | |
| 86038 | 0% | 742 | $0.00 | |
| 87075 | 0% | 360 | $0.00 | |
| 84403 | 0% | 447 | $0.00 | |
| 3077F | 0% | 154 | $0.00 | |
| 80305 | 0% | 56 | $0.00 | |
| 3720F | 0% | 130 | $0.00 | |
| 84450 | 0% | 665 | $0.00 | |
| 80373 | 0% | 54 | $0.00 | |
| 80326 | 0% | 43 | $0.00 | |
| 87210 | 0% | 667 | $0.00 | |
| 95144 | 0% | 910 | $0.00 | |
| 3725F | 0% | 129 | $0.00 | |
| 84550 | 0% | 1,554 | $0.00 | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | 0% | 161 | $0.00 |
| 3288F | 0% | 145 | $0.00 | |
| 86708 | 0% | 580 | $0.00 | |
| 82627 | 0% | 15 | $0.00 | |
| 1158F | 0% | 94 | $0.00 | |
| 99223 | Prolong inpt eval add15 m | 0% | 77 | $0.00 |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 462 | $0.00 |
| 86709 | 0% | 117 | $0.00 | |
| 72100 | 0% | 169 | $0.00 | |
| 82977 | 0% | 246 | $0.00 | |
| 85007 | 0% | 368 | $0.00 | |
| 82785 | 0% | 192 | $0.00 | |
| 99490 | Ccm add 20min | 0% | 187 | $0.00 |
| 84156 | 0% | 376 | $0.00 | |
| A6250 | Skin sealants, protectants, moisturizers, ointments, any type, any size | 0% | 87 | $0.00 |
| 84520 | 0% | 104 | $0.00 | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 0% | 156 | $0.00 |
| 90685 | 0% | 574 | $0.00 | |
| 84146 | 0% | 193 | $0.00 | |
| 80164 | 0% | 41 | $0.00 | |
| 90649 | 0% | 712 | $0.00 | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 0% | 213 | $0.00 |
| 84295 | 0% | 182 | $0.00 | |
| 82140 | 0% | 395 | $0.00 | |
| 80361 | 0% | 150 | $0.00 | |
| 93015 | 0% | 113 | $0.00 | |
| 87653 | 0% | 73 | $0.00 | |
| 80346 | 0% | 145 | $0.00 | |
| 80366 | 0% | 43 | $0.00 | |
| G9899 | Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed | 0% | 20 | $0.00 |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 0% | 31 | $0.00 |
| 82465 | 0% | 49 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 187 | $0.00 |
| 80377 | 0% | 43 | $0.00 | |
| G8730 | Pain assessment documented as positive using a standardized tool and a follow-up plan is documented | 0% | 202 | $0.00 |
| 92134 | 0% | 205 | $0.00 | |
| 73030 | 0% | 80 | $0.00 | |
| 86431 | 0% | 593 | $0.00 | |
| 90746 | 0% | 321 | $0.00 | |
| 90710 | 0% | 157 | $0.00 | |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 0% | 605 | $0.00 |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | 0% | 84 | $0.00 |
| 86703 | 0% | 194 | $0.00 | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | 0% | 12 | $0.00 |
| 77080 | 0% | 24 | $0.00 | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 0% | 28 | $0.00 |
| 80331 | 0% | 43 | $0.00 | |
| 99242 | 0% | 75 | $0.00 | |
| 85014 | 0% | 106 | $0.00 | |
| 94060 | 0% | 13 | $0.00 | |
| T4524 | Adult sized disposable incontinence product, brief/diaper, extra large, each | 0% | 42 | $0.00 |
| 83013 | 0% | 352 | $0.00 | |
| 76642 | 0% | 105 | $0.00 | |
| 72110 | 0% | 13 | $0.00 | |
| 86677 | 0% | 172 | $0.00 | |
| 76813 | 0% | 136 | $0.00 | |
| 82247 | 0% | 243 | $0.00 | |
| 1160F | 0% | 183 | $0.00 | |
| G9578 | Documentation of signed opioid treatment agreement at least once during opioid therapy | 0% | 214 | $0.00 |
| 20552 | 0% | 21 | $0.00 | |
| 69210 | 0% | 44 | $0.00 | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 0% | 30 | $0.00 |
| 83992 | 0% | 43 | $0.00 | |
| 86235 | 0% | 68 | $0.00 | |
| 93970 | 0% | 13 | $0.00 | |
| 80364 | 0% | 43 | $0.00 | |
| 73562 | 0% | 13 | $0.00 | |
| 84466 | 0% | 288 | $0.00 | |
| 80365 | 0% | 56 | $0.00 | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 0% | 22 | $0.00 |
| 67028 | Intravitreal injection of a pharmacologic agent | 0% | 134 | $0.00 |
| 82310 | 0% | 52 | $0.00 | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 0% | 28 | $0.00 |
| 99152 | 0% | 125 | $0.00 | |
| 87045 | 0% | 12 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 237 | $0.00 |
| 80202 | 0% | 240 | $0.00 | |
| 80355 | 0% | 43 | $0.00 | |
| S0191 | Misoprostol, oral, 200 mcg | 0% | 19 | $0.00 |
| 80370 | 0% | 43 | $0.00 | |
| 74018 | 0% | 58 | $0.00 | |
| 86644 | 0% | 13 | $0.00 | |
| 99053 | 0% | 14 | $0.00 | |
| 80344 | 0% | 43 | $0.00 | |
| 85041 | 0% | 16 | $0.00 | |
| S0190 | Mifepristone, oral, 200 mg | 0% | 16 | $0.00 |
| 85048 | 0% | 13 | $0.00 | |
| 82542 | 0% | 80 | $0.00 | |
| 89051 | 0% | 79 | $0.00 | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 0% | 12 | $0.00 |
| 80348 | 0% | 54 | $0.00 | |
| 86694 | 0% | 12 | $0.00 | |
| 80334 | 0% | 43 | $0.00 | |
| 80360 | 0% | 43 | $0.00 | |
| J7510 | Prednisolone oral, per 5 mg | 0% | 15 | $0.00 |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | 0% | 107 | $0.00 |
| 88164 | 0% | 17 | $0.00 | |
| 84681 | 0% | 13 | $0.00 | |
| 86665 | 0% | 32 | $0.00 | |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | 0% | 15 | $0.00 |
| 87902 | 0% | 14 | $0.00 | |
| 80337 | 0% | 43 | $0.00 | |
| 93224 | 0% | 12 | $0.00 | |
| G9622 | Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method | 0% | 34 | $0.00 |
| 77066 | Tomosynthesis, mammo | 0% | 13 | $0.00 |
| 85250 | 0% | 16 | $0.00 | |
| 77065 | Tomosynthesis, mammo | 0% | 13 | $0.00 |
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | 0% | 18 | $0.00 |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 0% | 13 | $0.00 |
| G8783 | Normal blood pressure reading documented, follow-up not required | 0% | 43 | $0.00 |
| 86705 | 0% | 16 | $0.00 | |
| 85652 | 0% | 1,087 | $0.00 | |
| 86060 | 0% | 98 | $0.00 | |
| 87015 | 0% | 33 | $0.00 | |
| 90698 | 0% | 1,661 | $0.00 | |
| 95117 | 0% | 4,851 | $0.00 | |
| 94010 | 0% | 925 | $0.00 | |
| 90744 | 0% | 1,111 | $0.00 | |
| 86850 | 0% | 837 | $0.00 | |
| 90657 | 0% | 553 | $0.00 | |
| 80329 | 0% | 148 | $0.00 | |
| 92551 | 0% | 4,710 | $0.00 | |
| 83021 | 0% | 203 | $0.00 | |
| 99285 | Emergency room visit (most serious) | 0% | 1,276 | $0.00 |
| 86140 | 0% | 801 | $0.00 | |
| D1206 | Topical application of fluoride varnish | 0% | 2,455 | $0.00 |
| A4335 | Incontinence supply; miscellaneous | 0% | 73 | $0.00 |
| 96151 | 0% | 360 | $0.00 | |
| H0049 | Alcohol and/or drug screening | 0% | 187 | $0.00 |
| 90651 | 0% | 865 | $0.00 | |
| 94200 | 0% | 4,637 | $0.00 | |
| 87430 | 0% | 67 | $0.00 | |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | 0% | 435 | $0.00 |
| 87797 | 0% | 185 | $0.00 | |
| 85013 | 0% | 536 | $0.00 | |
| 84436 | 0% | 1,521 | $0.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 343 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 109 | $0.00 |
| 88141 | 0% | 245 | $0.00 | |
| 96150 | 0% | 216 | $0.00 | |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | 0% | 383 | $0.00 |
| 86160 | 0% | 68 | $0.00 | |
| 83550 | 0% | 735 | $0.00 | |
| 94760 | 0% | 3,655 | $0.00 | |
| 86762 | 0% | 298 | $0.00 | |
| 84479 | 0% | 1,176 | $0.00 | |
| 97802 | 0% | 299 | $0.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 578 | $0.00 |
| G9008 | Coordinated care fee, physician coordinated care oversight services | 0% | 5,752 | $0.00 |
| 85730 | 0% | 941 | $0.00 | |
| 80069 | 0% | 245 | $0.00 | |
| 1170F | 0% | 165 | $0.00 | |
| 82746 | 0% | 1,891 | $0.00 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 0% | 565 | $0.00 |
| 86901 | 0% | 1,047 | $0.00 | |
| 90680 | 0% | 1,191 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 190 | $0.00 |
| 82670 | 0% | 100 | $0.00 | |
| 88304 | 0% | 12 | $0.00 | |
| 86695 | 0% | 419 | $0.00 | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 0% | 1,037 | $0.00 |
| 3075F | 0% | 215 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 2,092 | $0.00 |
| 86317 | 0% | 358 | $0.00 | |
| 7025F | 0% | 138 | $0.00 | |
| 87340 | 0% | 1,071 | $0.00 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 144 | $0.00 |
| 80367 | 0% | 43 | $0.00 | |
| 88142 | 0% | 943 | $0.00 | |
| 90620 | 0% | 314 | $0.00 | |
| 87503 | 0% | 306 | $0.00 | |
| 86141 | 0% | 714 | $0.00 | |
| 83605 | 0% | 1,623 | $0.00 | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 0% | 80 | $0.00 |
| 87486 | 0% | 156 | $0.00 | |
| 83921 | 0% | 46 | $0.00 | |
| 82150 | 0% | 581 | $0.00 | |
| 90716 | 0% | 1,039 | $0.00 | |
| 84478 | 0% | 158 | $0.00 | |
| 83883 | 0% | 92 | $0.00 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 0% | 201 | $0.00 |
| 83880 | 0% | 1,393 | $0.00 | |
| 1126F | 0% | 63 | $0.00 | |
| 80050 | General health panel | 0% | 1,107 | $0.00 |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 0% | 250 | $0.00 |
| 20553 | 0% | 158 | $0.00 | |
| 59430 | 0% | 106 | $0.00 | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 0% | 81 | $0.00 |
| 95886 | 0% | 110 | $0.00 | |
| 86706 | 0% | 757 | $0.00 | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 0% | 122 | $0.00 |
| S9451 | Exercise classes, non-physician provider, per session | 0% | 753 | $0.00 |
| 86225 | 0% | 81 | $0.00 | |
| 82533 | 0% | 12 | $0.00 | |
| 84480 | 0% | 795 | $0.00 | |
| 87510 | 0% | 1,505 | $0.00 | |
| 84153 | 0% | 1,016 | $0.00 | |
| 90688 | 0% | 1,001 | $0.00 | |
| 87480 | 0% | 1,506 | $0.00 | |
| 90723 | 0% | 24 | $0.00 | |
| 3079F | 0% | 532 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 58 | $0.00 |
| 82951 | 0% | 109 | $0.00 | |
| 17000 | 0% | 40 | $0.00 | |
| 83789 | 0% | 251 | $0.00 | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 0% | 244 | $0.00 |
| 85379 | 0% | 234 | $0.00 | |
| 86800 | 0% | 69 | $0.00 | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | 0% | 82 | $0.00 |
| 80357 | 0% | 43 | $0.00 | |
| 84132 | 0% | 466 | $0.00 | |
| G8755 | Most recent diastolic blood pressure >= 90 mmhg | 0% | 85 | $0.00 |
| 80055 | 0% | 262 | $0.00 | |
| 86255 | 0% | 49 | $0.00 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 0% | 1,232 | $0.00 |
| 83520 | 0% | 223 | $0.00 | |
| 80358 | 0% | 144 | $0.00 | |
| 84154 | 0% | 63 | $0.00 | |
| 99444 | 0% | 126 | $0.00 | |
| 99406 | 0% | 165 | $0.00 | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 0% | 555 | $0.00 |
| 87081 | 0% | 445 | $0.00 | |
| 90474 | 0% | 146 | $0.00 | |
| 3017F | 0% | 74 | $0.00 | |
| 87205 | 0% | 626 | $0.00 | |
| 84270 | 0% | 88 | $0.00 | |
| 80371 | 0% | 43 | $0.00 | |
| 86376 | 0% | 104 | $0.00 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 0% | 46 | $0.00 |
| 99460 | 0% | 132 | $0.00 | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 0% | 661 | $0.00 |
| T1014 | Telehealth transmission, per minute, professional services bill separately | 0% | 322 | $0.00 |
| 1000F | 0% | 30 | $0.00 | |
| 87581 | 0% | 193 | $0.00 | |
| 1125F | 0% | 33 | $0.00 | |
| 95115 | 0% | 122 | $0.00 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 80 | $0.00 |
| 84144 | 0% | 16 | $0.00 | |
| 76830 | Ultrasound, transvaginal | 0% | 156 | $0.00 |
| 82270 | 0% | 75 | $0.00 | |
| 83001 | 0% | 259 | $0.00 | |
| 80178 | 0% | 29 | $0.00 | |
| 73560 | 0% | 138 | $0.00 | |
| 81000 | 0% | 644 | $0.00 | |
| 82261 | 0% | 185 | $0.00 | |
| 3044F | 0% | 46 | $0.00 | |
| H2000 | Comprehensive multidisciplinary evaluation | 0% | 29 | $0.00 |
| 1036F | 0% | 29 | $0.00 | |
| 82803 | 0% | 626 | $0.00 | |
| 82105 | 0% | 106 | $0.00 | |
| 83498 | 0% | 182 | $0.00 | |
| 99239 | Hospital discharge day management, more than 30 minutes | 0% | 26 | $0.00 |
| 80359 | 0% | 54 | $0.00 | |
| 80081 | 0% | 56 | $0.00 | |
| 82950 | 0% | 515 | $0.00 | |
| G8950 | Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented | 0% | 85 | $0.00 |
| 80047 | 0% | 166 | $0.00 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 134 | $0.00 |
| 83615 | 0% | 179 | $0.00 | |
| 84402 | 0% | 16 | $0.00 | |
| 80341 | 0% | 43 | $0.00 | |
| 90696 | 0% | 190 | $0.00 | |
| 80349 | 0% | 51 | $0.00 | |
| Q3014 | Telehealth originating site facility fee | 0% | 322 | $0.00 |
| 80353 | 0% | 143 | $0.00 | |
| 1123F | 0% | 174 | $0.00 | |
| A4322 | Irrigation syringe, bulb or piston, each | 0% | 48 | $0.00 |
| 83002 | 0% | 201 | $0.00 | |
| 1111F | 0% | 65 | $0.00 | |
| 51798 | 0% | 107 | $0.00 | |
| 80368 | 0% | 43 | $0.00 | |
| 3014F | 0% | 20 | $0.00 | |
| 99070 | 0% | 42 | $0.00 | |
| 82952 | 0% | 41 | $0.00 | |
| 96111 | 0% | 120 | $0.00 | |
| 80324 | 0% | 91 | $0.00 | |
| 3080F | 0% | 41 | $0.00 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 0% | 88 | $0.00 |
| 96127 | 0% | 25 | $0.00 | |
| 87632 | 0% | 60 | $0.00 | |
| 80345 | 0% | 82 | $0.00 | |
| 11976 | 0% | 24 | $0.00 | |
| 84300 | 0% | 35 | $0.00 | |
| 98961 | 0% | 15 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 40 | $0.00 |
| 82378 | 0% | 44 | $0.00 | |
| J2785 | Injection, regadenoson, 0.1 mg | 0% | 30 | $0.00 |
| 83010 | 0% | 36 | $0.00 | |
| 71020 | 0% | 113 | $0.00 | |
| 87522 | Neg quan hep c or qual rna | 0% | 127 | $0.00 |
| A4253 | Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips | 0% | 24 | $0.00 |
| 90674 | 0% | 12 | $0.00 | |
| 85008 | 0% | 38 | $0.00 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 0% | 690 | $0.00 |
| 82784 | 0% | 13 | $0.00 | |
| 87147 | 0% | 30 | $0.00 | |
| 99462 | 0% | 94 | $0.00 | |
| 95911 | 0% | 54 | $0.00 | |
| 96156 | 0% | 12 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 14 | $0.00 |
| 90732 | 0% | 13 | $0.00 | |
| L3660 | Shoulder orthosis, figure of eight design abduction restrainer, canvas and webbing, prefabricated, off-the-shelf | 0% | 28 | $0.00 |
| 29075 | 0% | 13 | $0.00 | |
| 10040 | 0% | 15 | $0.00 | |
| 96910 | 0% | 52 | $0.00 | |
| 73620 | 0% | 13 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 18 | $0.00 |
| 87449 | 0% | 18 | $0.00 | |
| 87506 | 0% | 14 | $0.00 | |
| 83930 | 0% | 15 | $0.00 | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJAYASINGHE, WALTER (CEO)
| Provider | Location | Paid |
|---|---|---|
| Integrative Medical Center | Santa Ana, CA | $426K |
| Walter Jayasinghe MD Apac | Los Angeles, CA | $389K |
| Jayasinghe Medical Group INC | Los Angeles, CA | $182K |
| Walter Jayasinghe MD Apc | Los Angeles, CA | $24K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.